Covid-19 vaccines – Page 2 – pharmaceutical daily

December 7, 2021 Off

Medicago and GSK receive good news for its plant-based COVID-19 vaccine candidate

Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) have received positive efficacy and safety results from the global Phase 3 placebo-controlled efficacy study of Medicago’s plant-based COVID-19 vaccine candidate in combination with GSK’s pandemic adjuvant, conducted in over 24,000 subjects, adults 18 years and above, across six countries.

April 14, 2021 Off

FDA pauses vaccination with J&J vaccine after six cases of blood clot

By Author

U.S. CDC and FDA called for a pause in the J&J’s vaccine use following the emergence of a rare blood clotting disorder in six recipients.

April 9, 2021 Off

ImmunityBio Announces Single Prime hAd5 COVID-19 Vaccination Induces a 10-Fold Increase in T Cell Response Equivalent to T Cell Responses from Patients Previously Infected with SARS-CoV-2

By BusinessWire

Preliminary Phase 1b findings in participants receiving the dual antigen hAd5 S + N vaccine generated Th1 dominant S and…

April 1, 2021 Off

J&J answers allegations over vaccine problems

By Author

J&J has answered allegations about its batch of vaccines that could not be used after ingredient issues.

March 31, 2021 Off

Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna

By Author

EMA’s human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines…

March 25, 2021 Off

AstraZeneca answers accusation to stockpiling vaccines; 13M doses for COVAX, 16M for Europe

By Author

AstraZeneca has denied accusations of stockpiling vaccines stating that the process of manufacturing vaccines is very complex and time consuming…